Research Reports Initiation on Healthcare Stocks -- DaVita HealthCare Partners, AmSurg, Quintiles Transnational, and Acadia Healthcare

Sep 14, 2016, 09:12 ET from Chelmsford Park SA

NEW YORK, September 14, 2016 /PRNewswire/ --

Despite pricing, political, and regulatory pressures, Healthcare companies remain attractive to many investors due to the increasing aging population and the continuous demand for medicines, therapies, and other health care-related products and services. Ahead of today's trading session, is reviewing the current performances of the following stocks: DaVita HealthCare Partners Inc. (NYSE: DVA), AmSurg Corp. (NASDAQ: AMSG), Quintiles Transnational Holdings Inc. (NYSE: Q), and Acadia Healthcare Co. Inc. (NASDAQ: ACHC). Learn more about these stocks by downloading their free report at:

DaVita HealthCare Partners  

On Tuesday, shares in Denver, Colorado headquartered DaVita HealthCare Partners Inc. recorded a trading volume of 2.23 million shares, which was above their three months average volume of 1.41 million shares. The stock ended the session 1.17% lower at $63.95. The Company's shares are trading 10.64% below their 200-day moving average. Moreover, shares of DaVita HealthCare Partners, which provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease, have a Relative Strength Index (RSI) of 32.34.

As per notes filed with the SEC on September 6th, 2016, DaVita HealthCare Partners Inc. changed its name to DaVita Inc., effective September 1st, 2016. The name change was effected through an amendment to the company's certificate of incorporation pursuant to Section 242 of the Delaware General Corporation Law, which did not require stockholders' approval.

On September 6th, 2016, research firm Citigroup initiated a 'Neutral' rating on the Company's stock. The free research report on DVA is available at:


Nashville, Tennessee headquartered AmSurg Corp.'s stock closed the day 3.16% lower at $67.22 and with a total trading volume of 1.17 million shares. The Company's shares have advanced 0.63% in the past one month. The stock is trading 5.50% below its 50-day moving average. Additionally, shares of AmSurg, which through its subsidiaries, provides physician-centric surgical center and physician services in the US, have an RSI of 47.60.

On September 8th, 2016, Sheridan, the Physician Services division of AMSURG, announced that it has further expanded its anesthesiology services business and entered the Southern California market with its acquisition of Ambulatory Anesthesia Associates, Inc. and Genesis Anesthesia Services, Inc. The combined group employs 27 physicians covering six independent facilities, with Marina Del Rey Hospital representing its largest relationship. The complimentary report on AMSG can be downloaded at:

Quintiles Transnational Holdings  

Shares in Durham, North Carolina-based Quintiles Transnational Holdings Inc. recorded a trading volume of 1.02 million shares and ended yesterday's trading session 0.27% lower at $77.53. The stock has advanced 1.48% in the past one month, 18.97% in the previous three months, and 12.92% since the start of this year. The Company's shares are trading above their 50-day and 200-day moving averages by 3.45% and 13.93%, respectively. Furthermore, shares of Quintiles Transnational Holdings, which through its subsidiary, Quintiles Transnational Corp., provides biopharmaceutical development services and commercial outsourcing services in the Americas, Europe, Africa, and the Asia-Pacific, have an RSI of 59.21.

On September 12th, 2016, IMS Health Holdings, Inc. announced that its wholly owned subsidiary, IMS Health Incorporated, intends to raise $1.5 billion equivalent in gross proceeds through an offering of senior notes. The net proceeds from the notes offering will primarily be used to extinguish certain of the issuer's and Quintiles' existing indebtedness in connection with the previously announced proposed merger between IMS Health and Quintiles. On May 3rd, 2016, IMS Health Holdings and Quintiles Transnational had announced that the companies will be combined in an all-stock merger of equals transaction. The merged company will be named Quintiles IMS Holdings, Inc. Visit us today and download our complete research report on Q for free at:

Acadia Healthcare  

Franklin, Tennessee headquartered Acadia Healthcare Co. Inc.'s stock finished Tuesday's session 1.37% lower at $51.12 with a total trading volume of 469,111 shares. Shares of the Company, which develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the US, the UK, and Puerto Rico, are trading below their 50-day moving average by 3.18%. The stock has an RSI of 45.69.

On September 12th, 2016, Acadia Healthcare and Ochsner Health System announced an agreement to create a joint venture 82-bed acute psychiatric hospital, serving the greater New Orleans metropolitan area. Under the terms of the agreement, the new facility in LaPlace, LA, will be built in the current location of Ochsner's River Parishes' Emergency Room; Acadia will provide the investment to reconstruct the building, and handle day-to-day management of the facility. Get free access to your technical report on ACHC at:


Stock Callers: 

Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

SC has not been compensated; directly or indirectly; for producing or publishing this document. 


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  


SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: Phone number: +44 330 808 3765 Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Chelmsford Park SA